By paul.brackley@iliffemedia.co.uk (Paul Brackley) Healthy nerve cells will be transplanted into the brains of patients with Parkinson’s disease in an exciting clinical trial involving Cambridge researchers. The STEM-PD trial will use human embryonic stem cells – a type of cell with the ability to turn into almost any type of cell in the body. The cells have been programmed to develop into dopamine nerve cells that can be transplanted into the brains of patients to replace cells lost in Parkison’s disease. The product has been shown to be safe and effective at reverting motor deficits in anima…
